“U.S. policymakers misled by patent myths and manipulated data seem to be ignoring the economic and technological realities of biopharmaceutical innovation.” The following is condensed from an Issue ...
The New Civil Liberties Alliance (NCLA) this week filed a reply brief in the U.S. Supreme Court on behalf of U.S. Court of ...
On April 30, 2026, USPTO Director John A. Squires issued an updated memorandum on Best Practices for Submission of Rule 132 ...
Strong IP rights are the precursor to robust competition. Alden Abbott explains how efficient infringement rewards copycats ...
Most patent portfolios are overbuilt and under-managed. That is not a criticism of any particular company or patent ...
“All in all, inducement cannot be based only on ‘vague’ language ‘combined with speculation about how [others] may act.'” – SCOTUS opinion The U.S. Supreme Court today issued its decision in Hikma ...
In the latest episode of IP Innovators, host Steve Brachmann sits down with David Hyams, Co-Founder and Chief Business Development Officer of Longship Legal, to explore what it looks like to build an ...
“Pappas’ ‘rare combination of patent expertise and public service experience …makes him exceptionally well-qualified for this role.’” – Frank Cullen, C4IP Peter-Anthony Pappas, Director of ...
A district court on Monday denied motions to dismiss three copyright infringement lawsuits brought by a jury consultant ...